S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Amicus Therapeutics (FOLD) Insider Trading & Ownership

$10.33
-0.22 (-2.09%)
(As of 04/18/2024 ET)

Amicus Therapeutics (NASDAQ:FOLD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$6.81 M
Get FOLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amicus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FOLD Insider Buying and Selling by Quarter

Amicus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/5/2024Margaret G McglynnDirectorSell7,500$13.40$100,500.00  
2/15/2024Bradley L CampbellCEOSell4,167$14.00$58,338.00  
2/15/2024David Michael ClarkInsiderSell4,427$14.00$61,978.00  
2/15/2024John F CrowleyChairmanSell31,614$13.81$436,589.34  
2/6/2024Ellen RosenbergInsiderSell400$13.00$5,200.00  
1/22/2024John F CrowleyChairmanSell55,327$12.36$683,841.72  
1/16/2024John F CrowleyChairmanSell31,614$12.78$404,026.92  
1/10/2024John F CrowleyChairmanSell31,614$13.65$431,531.10  
1/9/2024David Michael ClarkInsiderSell1,384$14.00$19,376.00  
1/8/2024Samantha ProutCAOSell30,767$14.00$430,738.00  
1/2/2024Bradley L CampbellCEOSell15,833$14.23$225,303.59  
1/2/2024Ellen RosenbergInsiderSell30,000$14.21$426,300.00  
12/27/2023Ellen RosenbergInsiderSell5,000$14.07$70,350.00  
12/26/2023Samantha ProutCAOSell7,659$14.00$107,226.00  
12/19/2023Jeff CastelliInsiderSell17,500$13.25$231,875.00  
12/15/2023John F CrowleyChairmanSell6,043$12.66$76,504.38  
12/1/2023Bradley L CampbellCEOSell11,702$11.08$129,658.16  
12/1/2023John F CrowleyChairmanSell6,043$11.08$66,956.44  
11/15/2023John F CrowleyChairmanSell6,043$10.84$65,506.12  
11/1/2023Bradley L CampbellCEOSell11,700$10.97$128,349.00  
11/1/2023John F CrowleyChairmanSell6,044$10.97$66,302.68  
10/16/2023John F CrowleyChairmanSell6,044$10.50$63,462.00  
10/2/2023Bradley L CampbellCEOSell11,700$11.24$131,508.00  
10/2/2023John F CrowleyChairmanSell6,044$11.25$67,995.00  
9/15/2023John F CrowleyChairmanSell6,044$13.06$78,934.64  
9/1/2023Bradley L CampbellCEOSell18,093$12.97$234,666.21  
9/1/2023John F CrowleyChairmanSell6,044$12.98$78,451.12  
8/15/2023John F CrowleyChairmanSell6,044$13.03$78,753.32  
8/9/2023Samantha ProutCAOSell36,909$14.01$517,095.09  
8/1/2023Bradley L CampbellCEOSell20,000$13.39$267,800.00  
8/1/2023John F CrowleyChairmanSell6,044$13.35$80,687.40  
7/17/2023John F CrowleyChairmanSell6,044$13.45$81,291.80  
7/12/2023Bradley L CampbellCEOSell1,500$12.51$18,765.00  
7/3/2023Bradley L CampbellCEOSell11,700$12.31$144,027.00  
7/3/2023John F CrowleyChairmanSell6,044$12.31$74,401.64  
6/15/2023John F CrowleyChairmanSell6,044$13.04$78,813.76  
6/6/2023Bradley L CampbellCEOSell8,300$12.50$103,750.00  
6/1/2023Bradley L CampbellCEOSell11,700$11.36$132,912.00  
6/1/2023John F CrowleyChairmanSell6,044$11.36$68,659.84  
5/15/2023John F CrowleyChairmanSell6,044$11.18$67,571.92  
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
5/1/2023Bradley L CampbellCEOSell11,700$11.80$138,060.00  
5/1/2023John F CrowleyChairmanSell6,044$11.80$71,319.20  
(Data available from 1/1/2013 forward)

FOLD Insider Trading Activity - Frequently Asked Questions

Who is on Amicus Therapeutics's Insider Roster?
What percentage of Amicus Therapeutics stock is owned by insiders?

2.10% of Amicus Therapeutics stock is owned by insiders. Learn more on FOLD's insider holdings.

Which Amicus Therapeutics insiders have been selling company stock?

The following insiders have sold FOLD shares in the last 24 months: Bradley L Campbell ($2,694,498.26), Daphne Quimi ($102,014.00), David Michael Clark ($538,469.88), Ellen Rosenberg ($1,148,617.94), Jeff Castelli ($231,875.00), John F Crowley ($7,878,809.18), Margaret G Mcglynn ($400,800.00), Michael Raab ($49,942.64), and Samantha Prout ($1,055,059.09).

How much insider selling is happening at Amicus Therapeutics?

Insiders have sold a total of 1,160,463 Amicus Therapeutics shares in the last 24 months for a total of $14,100,085.99 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:FOLD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners